Viloxazine: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Viloxazine. Educational only — not medical advice.
Labeled uses
Qelbree is indicated for the treatment of Attention-Deficit Hyperactivity Disorder (ADHD) in adults and pediatric patients 6 years and older.
Source: FDA labeling via NIH DailyMed (set aedf408d…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.